PCM
GILD icon

Pinz Capital Management’s Gilead Sciences GILD Stock Holding History

Pinz Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,600
Closed -$103K – 463
2021
Q1 		$103K Sell
1,600
-5,500
-77% -$355K 0.03% 218
2020
Q4 		$414K Buy
+7,100
New +$428K 0.19% 80
2020
Q1 		– Sell
-35,000
Closed -$2.27M – 208
2019
Q4 		$2.27M Buy
+35,000
New +$2.28M 0.83% 76

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Pinz Capital Management's GILD Position: Q2 2021 in Review

Pinz Capital Management sold out of Gilead Sciences (GILD) in Q2 2021, closing a stake of 1,600 shares — an estimated $103K sold.

Pinz Capital Management first reported a position in GILD in Q4 2019 and held it in 3 quarters. The position peaked at $2.27M in Q4 2019. 1,544 funds tracked by Wall St. Rank hold GILD as of Q2 2021.

  • Pinz Capital Management reported no remaining Gilead Sciences position as of Q2 2021 after selling out during the quarter.
  • Pinz Capital Management sold 1,600 Gilead Sciences shares in Q2 2021, an estimated $103K.
  • Pinz Capital Management first reported a position in Gilead Sciences in Q4 2019 and held it in 3 quarters.
  • Pinz Capital Management's Gilead Sciences position peaked at $2.27M in Q4 2019.
  • 1,544 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.

Based on Pinz Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.